{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:46:22Z","timestamp":1773920782105,"version":"3.50.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Progesterone hypersensitivity is a rare and underdiagnosed condition whose incidence is expected to rise due to the increasing use of assisted reproductive technologies and exogenous progesterone exposure. This review aims to summarize the reported cases of endogenous and exogenous progesterone-induced anaphylaxis, focusing on clinical manifestations, diagnostic strategies, and management options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>\n                      A literature search through three data bases identified 25 documented cases of progesterone-induced anaphylaxis. Both endogenous (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200915) and exogenous (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910) exposures were implicated, with severe reactions including grade 4 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912) and grade 5 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091) anaphylaxis. Diagnostic evaluation commonly involved skin testing and challenge procedures, although heterogeneity in protocols was evident. Management strategies varied widely: some patients responded to hormonal modulation, while others required oophorectomy or treatment with monoclonal antibodies. Desensitization protocols were successfully implemented in selected cases, including in the context of in vitro fertilization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>PH should be recognized as a potentially life-threatening condition, particularly relevant for women of reproductive age undergoing assisted reproduction or hormonal therapy. By combining clinical insights with published examples of successful diagnostic and therapeutic strategies, this review aims to support clinicians in recognizing progesterone-induced anaphylaxis and implementing patient-centered management. Increased awareness is essential for early diagnosis and individualized treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11882-026-01267-4","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:09:14Z","timestamp":1773904154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["When Hormones Attack: A Literature Review of Progesterone-Induced Anaphylaxis"],"prefix":"10.1007","volume":"26","author":[{"given":"Roxana Silvia","family":"Bumb\u0103cea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denisa-Alexandra","family":"B\u0103loiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela Ruxandra","family":"Vintil\u0103","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Lucia","family":"Toader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selda","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"1267_CR1","doi-asserted-by":"publisher","unstructured":"Stanczyk FZ, Hapgood JP, Winer S, Introduction I, Potency B, Therapy H, Clinical Effects. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and. 2013;34(April):1\u201338. https:\/\/doi.org\/10.1210\/er.2012.","DOI":"10.1210\/er.2012"},{"key":"1267_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/jama.1964.03070140041004","volume":"190","author":"WB Shelley","year":"1964","unstructured":"Shelley WB, Preucel RW, Spoont SS. Autoimmune Progesterone Dermatitis. Cure By Oophorectomy. JAMA. 1964;190:35\u20138.","journal-title":"JAMA"},{"issue":"3","key":"1267_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1210\/jcem-55-3-597","volume":"55","author":"KL Cheesman","year":"1982","unstructured":"Cheesman KL, Gaynor LV, Chatterton RTJ, Radvany RM. Identification of a 17-hydroxyprogesterone-binding immunoglobulin in the serum of a woman with periodic rashes. J Clin Endocrinol Metab. 1982;55(3):597\u20139. https:\/\/doi.org\/10.1210\/jcem-55-3-597.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1267_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1346-8138.1992.tb03743.x","volume":"19","author":"CW Lee","year":"1992","unstructured":"Lee CW, Yoon KB, Yi JU, Cho SH. Autoimmune Progesterone Dermatitis. J Dermatol. 1992;19(10):629\u201331. https:\/\/doi.org\/10.1111\/j.1346-8138.1992.tb03743.x.","journal-title":"J Dermatol"},{"key":"1267_CR5","doi-asserted-by":"crossref","unstructured":"Naito T, Matsuyama S, Ogawa K et al. Ulcerative Colitis associated with autoimmune Progesterone Dermatitis. J Clin Gastroenterol. 1997;25(2). https:\/\/journals.lww.com\/jcge\/fulltext\/1997\/09000\/ulcerative_colitis_associated_with_autoimmune.22.aspx.","DOI":"10.1097\/00004836-199709000-00022"},{"issue":"9","key":"1267_CR6","doi-asserted-by":"publisher","first-page":"e44776","DOI":"10.7759\/cureus.44776","volume":"15","author":"G Dhaliwal","year":"2023","unstructured":"Dhaliwal G, Batra J, Ankireddypalli AR, Gorle S, Kanugula AK, Kaur J. Progesterone Hypersensitivity Induced by Exogenous Progesterone Exposure. Cureus. 2023;15(9):e44776. https:\/\/doi.org\/10.7759\/cureus.44776.","journal-title":"Cureus"},{"key":"1267_CR7","doi-asserted-by":"publisher","unstructured":"Bernstein JA. Progestogen Sensitization: a unique female presentation of Anaphylaxis. Curr Allergy Asthma Rep. 2020;20(1). https:\/\/doi.org\/10.1007\/s11882-020-0900-4.","DOI":"10.1007\/s11882-020-0900-4"},{"issue":"2","key":"1267_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.anai.2018.11.016","volume":"122","author":"WJ Lavery","year":"2019","unstructured":"Lavery WJ, Bernstein JA. Cyclical hypersensitivity, anaphylaxis, and related hormonal reaction. Ann Allergy Asthma Immunol. 2019;122(2):140\u20137. https:\/\/doi.org\/10.1016\/j.anai.2018.11.016.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"1267_CR9","first-page":"308","volume":"69","author":"T Miura","year":"1989","unstructured":"Miura T, Matsuda M, Yanbe H, Sugiyama S. Two cases of autoimmune progesterone dermatitis. Immunohistochemical and serological studies. Acta Derm Venereol. 1989;69(4):308\u201310.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"1267_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archderm.1969.01610190063011","volume":"99","author":"WN Jones","year":"1969","unstructured":"Jones WN, Gordon VH. Auto-immune progesterone eczema. An endogenous progesterone hypersensitivity. Arch Dermatol. 1969;99(1):57\u20139.","journal-title":"Arch Dermatol"},{"issue":"3","key":"1267_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/thorax.56.3.205","volume":"56","author":"XJ Zhao","year":"2001","unstructured":"Zhao XJ, McKerr G, Dong Z, et al. Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways. Thorax. 2001;56(3):205\u201311. https:\/\/doi.org\/10.1136\/thorax.56.3.205.","journal-title":"Thorax"},{"key":"1267_CR12","doi-asserted-by":"publisher","unstructured":"Zierau O, Zenclussen AC, Jensen F. Role of female sex hormones, estradiol and progesterone, in mast cell behavior. Front Immunol. 2012;3. https:\/\/doi.org\/10.3389\/fimmu.2012.00169.","DOI":"10.3389\/fimmu.2012.00169"},{"key":"1267_CR13","doi-asserted-by":"publisher","unstructured":"Gutierrez-Brito JA, Lomeli-Nieto Jalvaro, Munoz-Valle JF, Oregon-Romero E, Corona-Angeles JA, Hernandez-Bello J. Sex hormones and allergies: exploring the gender differences in immune responses. Front Allergy. 2025;5. https:\/\/doi.org\/10.3389\/falgy.2024.1483919.","DOI":"10.3389\/falgy.2024.1483919"},{"issue":"4","key":"1267_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/jwh.2010.2468","volume":"20","author":"IL Bernstein","year":"2011","unstructured":"Bernstein IL, Bernstein DI, Lummus ZL, Bernstein JA. A case of progesterone-induced anaphylaxis, cyclic urticaria\/angioedema, and autoimmune dermatitis. J Women\u2019s Heal. 2011;20(4):643\u20138. https:\/\/doi.org\/10.1089\/jwh.2010.2468.","journal-title":"J Women\u2019s Heal"},{"issue":"2","key":"1267_CR15","doi-asserted-by":"publisher","first-page":"AB21","DOI":"10.1016\/j.jaci.2018.12.062","volume":"143","author":"D Ghosh","year":"2019","unstructured":"Ghosh D, Bernstein JA. Evaluation of progesterone-specific serum IgE assay for diagnosis of suspected progesterone hypersensitivity. J Allergy Clin Immunol. 2019;143(2):AB21.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1267_CR16","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1590\/abd1806-4841.20187290","volume":"93","author":"JE Carrasco-Zuber","year":"2018","unstructured":"Carrasco-Zuber JE, \u00c1lvarez-V\u00e9liz S, Moll-Manzur C, Gonz\u00e1lez-Bombardiere S. Autoimmune progesterone dermatitis manifesting as generalized fixed drug eruption. Bras Dermatol. 2018;93(6):874\u20137. https:\/\/doi.org\/10.1590\/abd1806-4841.20187290.","journal-title":"Bras Dermatol"},{"issue":"12","key":"1267_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1346-8138.2009.00723.x","volume":"36","author":"J Asai","year":"2009","unstructured":"Asai J, Katoh N, Nakano M, Wada M, Kishimoto S. Case of autoimmune progesterone dermatitis presenting as fixed drug eruption. J Dermatol. 2009;36(12):643\u20135. https:\/\/doi.org\/10.1111\/j.1346-8138.2009.00723.x.","journal-title":"J Dermatol"},{"key":"1267_CR18","doi-asserted-by":"crossref","unstructured":"Mokhtari R, Sepaskhah M, Aslani FS, Dastgheib L. Autoimmune progesterone dermatitis presenting as fixed drug eruption: a case report. Dermatol Online J. 2017;23(6).","DOI":"10.5070\/D3236035381"},{"issue":"11","key":"1267_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/bcr-2019-231873","volume":"12","author":"N Bhardwaj","year":"2019","unstructured":"Bhardwaj N, Jindal R, Chauhan P. Autoimmune progesterone dermatitis presenting as fixed drug eruption. BMJ Case Rep. 2019;12(11):10\u20133. https:\/\/doi.org\/10.1136\/bcr-2019-231873.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"1267_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/ddg.12956","volume":"15","author":"A Salman","year":"2017","unstructured":"Salman A, Ergun T. Autoimmune progesterone dermatitis mimicking fixed drug eruption. J der Dtsch Dermatologischen Gesellschaft = J Ger Soc Dermatology JDDG. 2017;15(2):219\u201320. https:\/\/doi.org\/10.1111\/ddg.12956.","journal-title":"J der Dtsch Dermatologischen Gesellschaft = J Ger Soc Dermatology JDDG"},{"issue":"11","key":"1267_CR21","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/j.1600-0560.2010.01616.x","volume":"37","author":"TH McCalmont","year":"2010","unstructured":"McCalmont TH. Fact or fiction? J Cutan Pathol. 2010;37(11):1130\u20131. https:\/\/doi.org\/10.1111\/j.1600-0560.2010.01616.x.","journal-title":"J Cutan Pathol"},{"issue":"1","key":"1267_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/cup.12848","volume":"44","author":"T James","year":"2017","unstructured":"James T, Ghaferi J, LaFond A. The histopathologic features of autoimmune progesterone dermatitis. J Cutan Pathol. 2017;44(1):70\u20134. https:\/\/doi.org\/10.1111\/cup.12848.","journal-title":"J Cutan Pathol"},{"issue":"19","key":"1267_CR23","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJM198411083111909","volume":"311","author":"AL Sheffer","year":"1984","unstructured":"Sheffer AL. Unraveling the Mystery of Idiopathic Anaphylaxis. N Engl J Med. 1984;311(19):1248\u20139. https:\/\/doi.org\/10.1056\/NEJM198411083111909.","journal-title":"N Engl J Med"},{"issue":"4","key":"1267_CR24","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jaip.2016.03.003","volume":"4","author":"D Foer","year":"2016","unstructured":"Foer D, Buchheit KM, Gargiulo AR, Lynch DM, Castells M, Wickner PG. Progestogen Hypersensitivity in 24 Cases: Diagnosis, Management, and Proposed Renaming and Classification. J Allergy Clin Immunol Pract. 2016;4(4):723\u20139. https:\/\/doi.org\/10.1016\/j.jaip.2016.03.003.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1267_CR25","unstructured":"Cable JK, Grider MH. Physiology, Progesterone. StatPearls. StatPearls Publishing; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK558960\/."},{"key":"1267_CR26","doi-asserted-by":"publisher","unstructured":"Carmina E, Stanczyk FZ, Lobo RA. Chapter 34 - Laboratory Assessment. In: Strauss JF, Barbieri RL, eds. Yen & Jaffe\u2019s Reproductive Endocrinology (Seventh Edition). Seventh Ed. W.B. Saunders; 2014:822\u2013850.e3. https:\/\/doi.org\/10.1016\/B978-1-4557-2758-2.00034-2.","DOI":"10.1016\/B978-1-4557-2758-2.00034-2"},{"issue":"4","key":"1267_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/1744666X.2023.2182292","volume":"19","author":"DHH Patel","year":"2023","unstructured":"Patel DHH, Fine LMM, Bernstein JAA. A focused report on progestogen hypersensitivity. Expert Rev Clin Immunol. 2023;19(4):357\u201363. https:\/\/doi.org\/10.1080\/1744666X.2023.2182292.","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"1267_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.autrev.2015.11.003","volume":"15","author":"T Nguyen","year":"2016","unstructured":"Nguyen T, Ahmed AR. Autoimmune progesterone dermatitis: Update and insights. Autoimmun Rev. 2016;15(2):191\u20137. https:\/\/doi.org\/10.1016\/j.autrev.2015.11.003.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"1267_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4183\/aeb.2015.99","volume":"11","author":"RS Bumbacea","year":"2015","unstructured":"Bumbacea RS, Ghiordanescu IM, Tudose I, et al. Autoimmune progesterone dermatitis in a patient with no medical history of hormonal contraception or pregnancy. Acta Endocrinol (Copenh). 2015;11(1):99\u2013102. https:\/\/doi.org\/10.4183\/aeb.2015.99.","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"1267_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jaip.2017.01.019","volume":"5","author":"KM Buchheit","year":"2017","unstructured":"Buchheit KM, Bernstein JA. Progestogen Hypersensitivity: Heterogeneous Manifestations with a Common Trigger. J Allergy Clin Immunol Pract. 2017;5(3):566\u201374. https:\/\/doi.org\/10.1016\/j.jaip.2017.01.019.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"1267_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/humrep\/deae292","volume":"40","author":"Y Liang","year":"2025","unstructured":"Liang Y, Huang J, Zhao Q, et al. Global, regional, and national prevalence and trends of infertility among individuals of reproductive age (15\u201349 years) from 1990 to 2021, with projections to 2040. Hum Reprod. 2025;40(3):529\u201344. https:\/\/doi.org\/10.1093\/humrep\/deae292.","journal-title":"Hum Reprod"},{"issue":"1","key":"1267_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev"},{"issue":"10","key":"1267_CR33","doi-asserted-by":"publisher","first-page":"100472","DOI":"10.1016\/j.waojou.2020.100472","volume":"13","author":"V Cardona","year":"2020","unstructured":"Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020;13(10):100472. https:\/\/doi.org\/10.1016\/j.waojou.2020.100472.","journal-title":"World Allergy Organ J"},{"issue":"3","key":"1267_CR34","doi-asserted-by":"publisher","first-page":"100876","DOI":"10.1016\/j.waojou.2024.100876","volume":"17","author":"PJ Turner","year":"2024","unstructured":"Turner PJ, Ansotegui IJ, Campbell DE, et al. Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee. World Allergy Organ J. 2024;17(3):100876. https:\/\/doi.org\/10.1016\/j.waojou.2024.100876.","journal-title":"World Allergy Organ J"},{"issue":"11","key":"1267_CR35","first-page":"397","volume":"126","author":"GG Brooks","year":"1974","unstructured":"Brooks GG. Anaphylactoid shock with medroxyprogesterone acetate: A case report. J La State Med Soc Off organ La State Med Soc. 1974;126(11):397\u20139.","journal-title":"J La State Med Soc Off organ La State Med Soc"},{"issue":"1","key":"1267_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5694\/j.1326-5377.1982.tb132103.x","volume":"1","author":"R Zacest","year":"1982","unstructured":"Zacest R, Cushway A, Haines C, Cox LW. Hypersensitivity reaction to Depo-Provera. Med J Aust. 1982;1(1):12. https:\/\/doi.org\/10.5694\/j.1326-5377.1982.tb132103.x.","journal-title":"Med J Aust"},{"issue":"3","key":"1267_CR37","first-page":"158","volume":"38","author":"DS Rajapaksa","year":"1993","unstructured":"Rajapaksa DS. Anaphylaxis to Depo-Provera? Ceylon Med J. 1993;38(3):158\u20139.","journal-title":"Ceylon Med J"},{"issue":"2","key":"1267_CR38","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jaci.2004.05.031","volume":"114","author":"JA Poole","year":"2004","unstructured":"Poole JA, Rosenwasser LJ. Chronic idiopathic urticaria exacerbated with progesterone therapy treated with novel desensitization protocol. J Allergy Clin Immunol. 2004;114(2):456\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2004.05.031.","journal-title":"J Allergy Clin Immunol"},{"issue":"5 Pt 2","key":"1267_CR39","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/01.AOG.0000124573.05480.72","volume":"103","author":"DO Selo-Ojeme","year":"2004","unstructured":"Selo-Ojeme DO, Tillisi A, Welch CC. Anaphylaxis from medroxyprogesterone acetate. Obstet Gynecol. 2004;103(5 Pt 2):1045\u20136. https:\/\/doi.org\/10.1097\/01.AOG.0000124573.05480.72.","journal-title":"Obstet Gynecol"},{"key":"1267_CR40","doi-asserted-by":"publisher","unstructured":"Prieto-Garcia A, Sloane DE, Gargiulo AR, Feldweg AM, Castells M. Autoimmune progesterone dermatitis: clinical presentation and management with progesterone desensitization for successful in vitro fertilization. Fertil Steril. 2011;95(3). https:\/\/doi.org\/10.1016\/j.fertnstert.2010.10.038.","DOI":"10.1016\/j.fertnstert.2010.10.038"},{"issue":"2 Pt 2","key":"1267_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/AOG.0b013e318213cd49","volume":"118","author":"L Lestishock","year":"2011","unstructured":"Lestishock L, Pariseau C, Rooholamini S, Ammerman S. Anaphylaxis from depot medroxyprogesterone acetate in an adolescent girl. Obstet Gynecol. 2011;118(2 Pt 2):443\u20135. https:\/\/doi.org\/10.1097\/AOG.0b013e318213cd49.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"1267_CR42","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/jwh.2010.2468","volume":"20","author":"IL Bernstein","year":"2011","unstructured":"Bernstein IL, Bernstein DI, Lummus ZL, Bernstein JA. A Case of Progesterone-Induced Anaphylaxis, Cyclic Urticaria\/Angioedema, and Autoimmune Dermatitis. J WOMENS Heal. 2011;20(4):643\u20138. https:\/\/doi.org\/10.1089\/jwh.2010.2468.","journal-title":"J WOMENS Heal"},{"issue":"1","key":"1267_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4103\/jhrs.JHRS_116_17","volume":"11","author":"A Gupta","year":"2018","unstructured":"Gupta A, Goenka D, Goenka ML. Progesterone Hypersensitivity: A Challenge for Luteal Support. J Hum Reprod Sci. 2018;11(1):79\u201381. https:\/\/doi.org\/10.4103\/jhrs.JHRS_116_17.","journal-title":"J Hum Reprod Sci"},{"issue":"5 Pt 1","key":"1267_CR44","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/s0190-9622(96)90055-9","volume":"34","author":"DA Fisher","year":"1996","unstructured":"Fisher DA. Drug-induced progesterone dermatitis. J Am Acad Dermatol. 1996;34(5 Pt 1):863\u20134. https:\/\/doi.org\/10.1016\/s0190-9622(96)90055-9.","journal-title":"J Am Acad Dermatol"},{"key":"1267_CR45","doi-asserted-by":"publisher","unstructured":"Aghazadeh N, Berry NA, Torgerson RR, Park MA, Davis DMR. Autoimmune progesterone dermatitis: a retrospective case series. Int J Womens Dermatology. 2022;8(3). https:\/\/doi.org\/10.1097\/JW9.0000000000000009.","DOI":"10.1097\/JW9.0000000000000009"},{"issue":"6","key":"1267_CR46","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/00006254-198506000-00018","volume":"40","author":"WJ Meggs","year":"1985","unstructured":"Meggs WJ, Pescovitz OH, Metcalfe D, Loriaux DL, Cutler G, Kaliner M. Progesterone sensitivity as a cause of recurrent anaphylaxis. Obstet Gynecol Surv. 1985;40(6):372\u20133. https:\/\/doi.org\/10.1097\/00006254-198506000-00018.","journal-title":"Obstet Gynecol Surv"},{"issue":"4","key":"1267_CR47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ijoa.2004.03.003","volume":"13","author":"J O\u2019Rourke","year":"2004","unstructured":"O\u2019Rourke J, Khawaja N, Loughrey J, McKenna P. Autoimmune progesterone dermatitis in a parturient for emergency caesarean section. Int J Obstet Anesth. 2004;13(4):275\u20138. https:\/\/doi.org\/10.1016\/j.ijoa.2004.03.003.","journal-title":"Int J Obstet Anesth"},{"issue":"1","key":"1267_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0738-081X(96)00107-1","volume":"15","author":"CJM Stephens","year":"1997","unstructured":"Stephens CJM. Perimenstrual eruptions. Clin Dermatol. 1997;15(1):31\u20134. https:\/\/doi.org\/10.1016\/S0738-081X(96)00107-1.","journal-title":"Clin Dermatol"},{"key":"1267_CR49","unstructured":"Slater JE, Raphael G, Cutler GB, Loriaux DL, Meggs WJ, Kaliner M. Recurrent anaphylaxis in menstruating women: treatment with a luteinizing hormone-releasing hormone agonist-A preliminary report. Obstet Gynecol. 1987;70(4):542\u2013546. https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-0023226269&partnerID=40&md5=0ab57be443956c6fb565abc138ad1b9c."},{"key":"1267_CR50","doi-asserted-by":"publisher","first-page":"757854","DOI":"10.1155\/2012\/757854","volume":"2012","author":"R George","year":"2012","unstructured":"George R, Badawy SZA. Autoimmune progesterone dermatitis: a case report. Case Rep Obstet Gynecol. 2012;2012:757854. https:\/\/doi.org\/10.1155\/2012\/757854.","journal-title":"Case Rep Obstet Gynecol"},{"issue":"5","key":"1267_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0091-6749(71)90025-x","volume":"48","author":"FS Farah","year":"1971","unstructured":"Farah FS, Shbaklu Z. Autoimmune progesterone urticaria. J Allergy Clin Immunol. 1971;48(5):257\u201361. https:\/\/doi.org\/10.1016\/0091-6749(71)90025-x.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1267_CR52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1440-0960.1981.tb00039.x","volume":"22","author":"K Georgouras","year":"1981","unstructured":"Georgouras K. Autoimmune progesterone dermatitis. Australas J Dermatol. 1981;22(3):109\u201312. https:\/\/doi.org\/10.1111\/j.1440-0960.1981.tb00039.x.","journal-title":"Australas J Dermatol"},{"key":"1267_CR53","doi-asserted-by":"publisher","unstructured":"Huang Y, Ye S, Bao X, Yang R, Huang J. Whole course of treatment of autoimmune progesterone dermatitis that had spontaneously resolved during pregnancy: a case report and review of the literature. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.939083.","DOI":"10.3389\/fimmu.2022.939083"},{"issue":"2","key":"1267_CR54","first-page":"311","volume":"47","author":"S Halevy","year":"2002","unstructured":"Halevy S, Cohen AD, Lunenfeld E, Grossman N. Autoimmune progesterone dermatitis manifested as erythema annulare centrifugum: Confirmation of progesterone sensitivity by in vitro interferon-gamma release. J Am Acad Dermatol. 2002;47(2):311\u20133.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1267_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1365-2133.1989.tb01410.x","volume":"121","author":"CJ Stephens","year":"1989","unstructured":"Stephens CJ, Wojnarowska FT, Wilkinson JD. Autoimmune progesterone dermatitis responding to Tamoxifen. Br J Dermatol. 1989;121(1):135\u20137. https:\/\/doi.org\/10.1111\/j.1365-2133.1989.tb01410.x.","journal-title":"Br J Dermatol"},{"issue":"12","key":"1267_CR56","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1016\/j.jaip.2023.07.050","volume":"11","author":"SE Chiarella","year":"2023","unstructured":"Chiarella SE, Buchheit KM, Foer D. Progestogen Hypersensitivity. J ALLERGY Clin Immunol Pract. 2023;11(12):3606. https:\/\/doi.org\/10.1016\/j.jaip.2023.07.050.","journal-title":"J ALLERGY Clin Immunol Pract"},{"issue":"6","key":"1267_CR57","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/archderm.1973.01620210060016","volume":"107","author":"SM Bierman","year":"1973","unstructured":"Bierman SM. Autoimmune progesterone dermatitis of pregnancy. Arch Dermatol. 1973;107(6):896\u2013901.","journal-title":"Arch Dermatol"},{"issue":"4","key":"1267_CR58","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-2230.2010.03979.x","volume":"36","author":"LM Toms-Whittle","year":"2011","unstructured":"Toms-Whittle LM, John LH, Griffiths DJ, Buckley DA. Autoimmune progesterone dermatitis: A diagnosis easily missed. Clin Exp Dermatol. 2011;36(4):378\u201380. https:\/\/doi.org\/10.1111\/j.1365-2230.2010.03979.x.","journal-title":"Clin Exp Dermatol"},{"issue":"2 Pt 2","key":"1267_CR59","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0190-9622(95)90398-4","volume":"32","author":"AJ Herzberg","year":"1995","unstructured":"Herzberg AJ, Strohmeyer CR, Cirillo-Hyland VA. Autoimmune progesterone dermatitis. J Am Acad Dermatol. 1995;32(2 Pt 2):333\u20138. https:\/\/doi.org\/10.1016\/0190-9622(95)90398-4.","journal-title":"J Am Acad Dermatol"},{"key":"1267_CR60","doi-asserted-by":"publisher","unstructured":"Varghese A, Paul T, Kim H, Van Uum S, Vadas P, Azzola A. Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report. Allergy Asthma Clin Immunol. 2021;17(1). https:\/\/doi.org\/10.1186\/s13223-021-00561-2.","DOI":"10.1186\/s13223-021-00561-2"},{"issue":"4","key":"1267_CR61","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1001\/archderm.1977.01640040034003","volume":"113","author":"R Hart","year":"1977","unstructured":"Hart R. Autoimmune progesterone dermatitis. Arch Dermatol. 1977;113(4):426\u201330.","journal-title":"Arch Dermatol"},{"issue":"5","key":"1267_CR62","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1081-1206(10)61838-8","volume":"90","author":"JL Snyder","year":"2003","unstructured":"Snyder JL, Krishnaswamy G. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: A case report and literature review. Ann Allergy Asthma Immunol. 2003;90(5):469\u201377. https:\/\/doi.org\/10.1016\/S1081-1206(10)61838-8.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"1267_CR63","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ijoa.2004.03.003","volume":"13","author":"J O\u2019Rourke","year":"2004","unstructured":"O\u2019Rourke J, Khawaja N, Loughrey J, McKenna P. Autoimmune progesterone dermatitis in a parturient for emergency caesarean section. Int J Obstet Anesth. 2004;13(4):275\u20138. https:\/\/doi.org\/10.1016\/j.ijoa.2004.03.003.","journal-title":"Int J Obstet Anesth"},{"key":"1267_CR64","unstructured":"Bemanian MH, Gharagozlu M, Farashahi MH, Nabavi M, Shirkhoda Z. Autoimmune progesterone anaphylaxis. Iran J Allergy, Asthma Immunol. 2007;6(2):97\u201399. https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-34547635114&partnerID=40&md5=8eb6200ce5fc16976f16a0434b5869be."},{"key":"1267_CR65","unstructured":"Magen E, Feldman V. Autoimmune progesterone anaphylaxis in a 24 year old woman. Isr Med Assoc J. 2012;14(8):518\u2013519. https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-84866128311&partnerID=40&md5=702be6c53e4086a759c018a8a913fb5c."},{"issue":"5","key":"1267_CR66","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/1346-8138.12473","volume":"41","author":"T Honda","year":"2014","unstructured":"Honda T, Kabashima K, Fujii Y, Katoh M, Miyachi Y. Autoimmune progesterone dermatitis that changed its clinical manifestation from anaphylaxis to fixed drug eruption-like erythema. J Dermatol. 2014;41(5):447\u20138. https:\/\/doi.org\/10.1111\/1346-8138.12473.","journal-title":"J Dermatol"},{"issue":"12","key":"1267_CR67","doi-asserted-by":"publisher","first-page":"738","DOI":"10.7556\/jaoa.2015.150","volume":"115","author":"A DeRosa","year":"2015","unstructured":"DeRosa A, Adams S, Fee EK. Progressively Worsening Cyclic Rash: Diagnosis and Approach to Care. J Am Osteopath Assoc. 2015;115(12):738\u201344. https:\/\/doi.org\/10.7556\/jaoa.2015.150.","journal-title":"J Am Osteopath Assoc"},{"key":"1267_CR68","doi-asserted-by":"publisher","unstructured":"Lin K, Rasheed A, Lin S, Gerolemou L. Catamenial anaphylaxis: a woman under monthly progesterone curse. BMJ Case Rep. 2018;2018. https:\/\/doi.org\/10.1136\/bcr-2017-222047.","DOI":"10.1136\/bcr-2017-222047"},{"issue":"3","key":"1267_CR69","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jaip.2017.01.003","volume":"5","author":"E Heffler","year":"2017","unstructured":"Heffler E, Fichera S, Nicolosi G, Crimi N. Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumab. J Allergy Clin Immunol Pract. 2017;5(3):852\u20134. https:\/\/doi.org\/10.1016\/j.jaip.2017.01.003.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"1267_CR70","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/pde.14423","volume":"38","author":"N Aghazadeh","year":"2021","unstructured":"Aghazadeh N, Chattha AJ, Hartz MF, Davis DMR. Autoimmune progesterone dermatitis in the adolescent population. Pediatr Dermatol. 2021;38(2):380\u20134. https:\/\/doi.org\/10.1111\/pde.14423.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"1267_CR71","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1600-0536.1994.tb01928.x","volume":"31","author":"CJ Stephens","year":"1994","unstructured":"Stephens CJ, McFadden JP, Black MM, Rycroft RJ. Autoimmune progesterone dermatitis: absence of contact sensitivity to glucocorticoids, oestrogen and 17-alpha-OH-progesterone. Contact Dermat. 1994;31(2):108\u201310. https:\/\/doi.org\/10.1111\/j.1600-0536.1994.tb01928.x.","journal-title":"Contact Dermat"},{"issue":"3","key":"1267_CR72","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.fertnstert.2010.10.038","volume":"95","author":"A Prieto-Garcia","year":"2011","unstructured":"Prieto-Garcia A, Sloane DE, Gargiulo AR, Feldweg AM, Castells M. Autoimmune progesterone dermatitis: Clinical presentation and management with progesterone desensitization for successful in vitro fertilization. Fertil Steril. 2011;95(3):1121. .e9-1121.e13.","journal-title":"Fertil Steril"},{"key":"1267_CR73","doi-asserted-by":"publisher","unstructured":"Sandru F, Dumitrascu MC, Petca A, Petca RC, Roman AM. Progesterone hypersensitivity in assisted reproductive technologies: implications for safety and efficacy. J Pers Med. 2024;14(1). https:\/\/doi.org\/10.3390\/jpm14010079.","DOI":"10.3390\/jpm14010079"},{"key":"1267_CR74","doi-asserted-by":"publisher","unstructured":"Li RC, Buchheit KM, Bernstein JA. Progestogen hypersensitivity. Curr Allergy Asthma Rep. 2018;18(1). https:\/\/doi.org\/10.1007\/s11882-018-0758-x.","DOI":"10.1007\/s11882-018-0758-x"},{"issue":"4","key":"1267_CR75","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.iac.2017.07.006","volume":"37","author":"D Foer","year":"2017","unstructured":"Foer D, Buchheit KM. Progestogen Hypersensitivity: An Evidence-Based Approach to Diagnosis and Management in Clinical Practice. Immunol Allergy Clin North Am. 2017;37(4):773\u201384. https:\/\/doi.org\/10.1016\/j.iac.2017.07.006.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"9","key":"1267_CR76","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","volume":"8","author":"AD Broyles","year":"2020","unstructured":"Broyles AD, Banerji A, Barmettler S, et al. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. J Allergy Clin Immunol Pract. 2020;8(9):S16\u2013116. https:\/\/doi.org\/10.1016\/j.jaip.2020.08.006.","journal-title":"J ALLERGY Clin Immunol Pract"},{"issue":"5","key":"1267_CR77","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/ced.14664","volume":"46","author":"H Geros","year":"2021","unstructured":"Geros H, Maor D, Higgins C, Bala HR, Nixon R. Intradermal testing for autoimmune progesterone dermatitis: should we be basing the diagnosis on it? Clin Exp Dermatol. 2021;46(5):906\u20139. https:\/\/doi.org\/10.1111\/ced.14664.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"1267_CR78","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/S0015-0282(03)01170-1","volume":"80","author":"JL Phy","year":"2003","unstructured":"Phy JL, Weiss WT, Weiler CR, Damario MA. Hypersensitivity to progesterone-in-oil after in vitro fertilization and embryo transfer. Fertil Steril. 2003;80(5):1272\u20135. https:\/\/doi.org\/10.1016\/S0015-0282(03)01170-1.","journal-title":"Fertil Steril"},{"issue":"3","key":"1267_CR79","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jaip.2017.01.003","volume":"5","author":"E Heffler","year":"2017","unstructured":"Heffler E, Fichera S, Nicolosi G, Crimi N. Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumab. J Allergy Clin Immunol Pract. 2017;5(3):852\u20134. https:\/\/doi.org\/10.1016\/j.jaip.2017.01.003.","journal-title":"J ALLERGY Clin Immunol Pract"},{"issue":"5","key":"1267_CR80","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000250305","volume":"162","author":"R Friedman-Birnbaum","year":"1981","unstructured":"Friedman-Birnbaum R, Gilhar A, Haim S. Sensitivity to endogenous progesterone. Report of a case. Dermatologica. 1981;162(5):391\u20134. https:\/\/doi.org\/10.1159\/000250305.","journal-title":"Dermatologica"},{"key":"1267_CR81","doi-asserted-by":"publisher","unstructured":"Bello CDA, Guzman OPG, Coello CVM, Gutierrez MIR, Vazquez MIC. Diagnostic tests for progestogen hypersensitivity. Front ALLERGY. 2024;5. https:\/\/doi.org\/10.3389\/falgy.2024.1384140.","DOI":"10.3389\/falgy.2024.1384140"},{"key":"1267_CR82","doi-asserted-by":"publisher","unstructured":"Slater JE, Kaliner M. Effects of sex hormones on basophil histamine release in recurrent idiopathic anaphylaxis. J Allergy Clin Immunol. 1987;80(3 PART 1):285\u2013290. https:\/\/doi.org\/10.1016\/0091-6749(87)90033-9.","DOI":"10.1016\/0091-6749(87)90033-9"},{"issue":"19","key":"1267_CR83","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1056\/NEJM198411083111907","volume":"311","author":"WJ Meggs","year":"1984","unstructured":"Meggs WJ, Pescovitz OH, Metcalfe D, Loriaux DL, Cutler G, Kaliner M. Progesterone Sensitivity as a Cause of Recurrent Anaphylaxis. N Engl J Med. 1984;311(19):1236\u20138. https:\/\/doi.org\/10.1056\/NEJM198411083111907.","journal-title":"N Engl J Med"},{"issue":"10","key":"1267_CR84","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/imj.16517","volume":"54","author":"G Xu","year":"2024","unstructured":"Xu G, Yuson R, Rafferty M, Thai TL, Limaye S. Progestogen hypersensitivity: successful use of progesterone desensitisation and omalizumab to facilitate in vitro fertilisation. Intern Med J. 2024;54(10):1749\u201352. https:\/\/doi.org\/10.1111\/imj.16517.","journal-title":"Intern Med J"},{"issue":"5","key":"1267_CR85","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jaip.2013.06.005","volume":"1","author":"JL Hill","year":"2013","unstructured":"Hill JL, Carr TF. Iatrogenic autoimmune progesterone dermatitis treated with a novel intramuscular progesterone desensitization protocol. J Allergy Clin Immunol Pract. 2013;1(5):537\u20138. https:\/\/doi.org\/10.1016\/j.jaip.2013.06.005.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"1267_CR86","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1046\/j.1365-4362.1997.00105.x","volume":"36","author":"E Shahar","year":"1997","unstructured":"Shahar E, Bergman R, Pollack S. Autoimmune progesterone dermatitis: effective prophylactic treatment with danazol. Int J Dermatol. 1997;36(9):708\u201311. https:\/\/doi.org\/10.1046\/j.1365-4362.1997.00105.x.","journal-title":"Int J Dermatol"},{"issue":"2","key":"1267_CR87","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/1346-8138.15180","volume":"47","author":"M Zhang","year":"2020","unstructured":"Zhang M, Tang X, Zhou H, Liao Q, Han J. Case of autoimmune progesterone dermatitis presenting as necrotic migratory erythema successfully controlled by danazol. J Dermatol. 2020;47(2):178\u201380. https:\/\/doi.org\/10.1111\/1346-8138.15180.","journal-title":"J Dermatol"},{"issue":"3","key":"1267_CR88","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jpag.2023.12.006","volume":"37","author":"A Claffey","year":"2024","unstructured":"Claffey A, Evans M, Mauskar M, Jarin J. Progesterone Hypersensitivity: The Utility of a Janus Kinase Inhibitor for Recurrent Erythema Multiforme. J Pediatr Adolesc Gynecol. 2024;37(3):378\u201380. https:\/\/doi.org\/10.1016\/j.jpag.2023.12.006.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"1267_CR89","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2230.2001.00747.x","volume":"26","author":"AP Warin","year":"2001","unstructured":"Warin AP. Case 2. Clin Exp Dermatol. 2001;26(1):107\u20138. https:\/\/doi.org\/10.1046\/j.1365-2230.2001.00747.x.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"1267_CR90","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2310\/6620.2006.05045","volume":"17","author":"D Stranahan","year":"2006","unstructured":"Stranahan D, Rausch D, Deng A, Gaspari A. The role of intradermal skin testing and patch testing in the diagnosis of autoimmune progesterone dermatitis. Dermatitis. 2006;17(1):39\u201342. https:\/\/doi.org\/10.2310\/6620.2006.05045.","journal-title":"Dermatitis"},{"issue":"2","key":"1267_CR91","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0190-9622(90)70040-O","volume":"22","author":"EA Leitao","year":"1990","unstructured":"Leitao EA, Bernhard JD. Perimenstrual nonvesicular dermatitis herpetiformis. J Am Acad Dermatol. 1990;22(2):331\u20134. https:\/\/doi.org\/10.1016\/0190-9622(90)70040-O.","journal-title":"J Am Acad Dermatol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-026-01267-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-026-01267-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-026-01267-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:09:18Z","timestamp":1773904158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-026-01267-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1267"],"URL":"https:\/\/doi.org\/10.1007\/s11882-026-01267-4","relation":{},"ISSN":["1534-6315"],"issn-type":[{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}